BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 25828894)

  • 21. Overexpression of caldesmon is associated with lymph node metastasis and poorer prognosis in patients with oral cavity squamous cell carcinoma.
    Chang KP; Wang CL; Kao HK; Liang Y; Liu SC; Huang LL; Hseuh C; Hsieh YJ; Chien KY; Chang YS; Yu JS; Chi LM
    Cancer; 2013 Nov; 119(22):4003-11. PubMed ID: 23963810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stromal expression of neutrophil gelatinase-associated lipocalin correlates with poor differentiation and adverse prognosis in oral squamous cell carcinoma.
    Shinriki S; Jono H; Ueda M; Obayashi K; Nakamura T; Ota K; Ota T; Sueyoshi T; Guo J; Hayashi M; Hiraki A; Nakayama H; Yamashita S; Shinohara M; Ando Y
    Histopathology; 2014 Feb; 64(3):356-64. PubMed ID: 24118080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased tumor-infiltrating plasmacytoid dendritic cells predicts poor prognosis in oral squamous cell carcinoma.
    Han N; Zhang Z; Liu S; Ow A; Ruan M; Yang W; Zhang C
    Arch Oral Biol; 2017 Jun; 78():129-134. PubMed ID: 28242507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Absent and abundant MET immunoreactivity is associated with poor prognosis of patients with oral and oropharyngeal squamous cell carcinoma.
    De Herdt MJ; Willems SM; van der Steen B; Noorlag R; Verhoef EI; van Leenders GJ; van Es RJ; KoljenoviÄ S; Baatenburg de Jong RJ; Looijenga LH
    Oncotarget; 2016 Mar; 7(11):13167-81. PubMed ID: 26909606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumour budding evaluated in biopsy specimens is a useful predictor of prognosis in patients with cN0 early stage oral squamous cell carcinoma.
    Seki M; Sano T; Yokoo S; Oyama T
    Histopathology; 2017 May; 70(6):869-879. PubMed ID: 27926795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The paracrine effect of cancer-associated fibroblast-induced interleukin-33 regulates the invasiveness of head and neck squamous cell carcinoma.
    Chen SF; Nieh S; Jao SW; Wu MZ; Liu CL; Chang YC; Lin YS
    J Pathol; 2013 Oct; 231(2):180-9. PubMed ID: 23775566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subcellular differential expression of Ep-ICD in oral dysplasia and cancer is associated with disease progression and prognosis.
    Somasundaram RT; Kaur J; Leong I; MacMillan C; Witterick IJ; Walfish PG; Ralhan R
    BMC Cancer; 2016 Jul; 16():486. PubMed ID: 27421772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
    Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
    Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and Biological Significance of PD-L1 Expression Within the Tumor Microenvironment of Oral Squamous Cell Carcinoma.
    Takahashi H; Sakakura K; Arisaka Y; Tokue A; Kaira K; Tada H; Higuchi T; Okamoto A; Tsushima Y; Chikamatsu K
    Anticancer Res; 2019 Jun; 39(6):3039-3046. PubMed ID: 31177146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased expression of interleukin-6 predicts poor response to chemoradiotherapy and unfavorable prognosis in oral squamous cell carcinoma.
    Jinno T; Kawano S; Maruse Y; Matsubara R; Goto Y; Sakamoto T; Hashiguchi Y; Kaneko N; Tanaka H; Kitamura R; Toyoshima T; Jinno A; Moriyama M; Oobu K; Kiyoshima T; Nakamura S
    Oncol Rep; 2015 May; 33(5):2161-8. PubMed ID: 25761055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Collagen Triple Helix Repeat Containing-1 (CTHRC1) Expression in Oral Squamous Cell Carcinoma (OSCC): Prognostic Value and Clinico-Pathological Implications.
    Lee CE; Vincent-Chong VK; Ramanathan A; Kallarakkal TG; Karen-Ng LP; Ghani WM; Rahman ZA; Ismail SM; Abraham MT; Tay KK; Mustafa WM; Cheong SC; Zain RB
    Int J Med Sci; 2015; 12(12):937-45. PubMed ID: 26664254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p16 expression independent of human papillomavirus is associated with lower stage and longer disease-free survival in oral cavity squamous cell carcinoma.
    Satgunaseelan L; Virk SA; Lum T; Gao K; Clark JR; Gupta R
    Pathology; 2016 Aug; 48(5):441-8. PubMed ID: 27370365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of FoxP3 and CTLA-4 expression in patients with oral squamous cell carcinoma.
    Koike K; Dehari H; Ogi K; Shimizu S; Nishiyama K; Sonoda T; Sasaki T; Sasaya T; Tsuchihashi K; Hasegawa T; Torigoe T; Hiratsuka H; Miyazaki A
    PLoS One; 2020; 15(8):e0237465. PubMed ID: 32785290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased expression of Toll-like receptor-9 has close relation with tumour cell proliferation in oral squamous cell carcinoma.
    Min R; Zun Z; Siyi L; Wenjun Y; Lizheng W; Chenping Z
    Arch Oral Biol; 2011 Sep; 56(9):877-84. PubMed ID: 21333270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of podoplanin in the invasion front of oral squamous cell carcinoma is not prognostic for survival.
    de Vicente JC; Santamarta TR; Rodrigo JP; García-Pedrero JM; Allonca E; Blanco-Lorenzo V
    Virchows Arch; 2015 May; 466(5):549-58. PubMed ID: 25726183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fractal analysis of nuclear histology integrates tumor and stromal features into a single prognostic factor of the oral cancer microenvironment.
    Bose P; Brockton NT; Guggisberg K; Nakoneshny SC; Kornaga E; Klimowicz AC; Tambasco M; Dort JC
    BMC Cancer; 2015 May; 15():409. PubMed ID: 25976920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ultra-deep targeted sequencing of advanced oral squamous cell carcinoma identifies a mutation-based prognostic gene signature.
    Chen SJ; Liu H; Liao CT; Huang PJ; Huang Y; Hsu A; Tang P; Chang YS; Chen HC; Yen TC
    Oncotarget; 2015 Jul; 6(20):18066-80. PubMed ID: 25980437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Novel Digital Score for Abundance of Tumour Infiltrating Lymphocytes Predicts Disease Free Survival in Oral Squamous Cell Carcinoma.
    Shaban M; Khurram SA; Fraz MM; Alsubaie N; Masood I; Mushtaq S; Hassan M; Loya A; Rajpoot NM
    Sci Rep; 2019 Sep; 9(1):13341. PubMed ID: 31527658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Composition and Clinical Impact of the Immunologic Tumor Microenvironment in Oral Squamous Cell Carcinoma.
    Boxberg M; Leising L; Steiger K; Jesinghaus M; Alkhamas A; Mielke M; Pfarr N; Götz C; Wolff KD; Weichert W; Kolk A
    J Immunol; 2019 Jan; 202(1):278-291. PubMed ID: 30530592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating CD105 shows significant impact in patients of oral cancer and promotes malignancy of cancer cells via CCL20.
    Chen CH; Chuang HC; Lin YT; Fang FM; Huang CC; Chen CM; Lu H; Chien CY
    Tumour Biol; 2016 Feb; 37(2):1995-2005. PubMed ID: 26334621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.